Sign Up

Resuming production in Northern Ireland

Terex has taken the decision to resume production at a reduced capacity at all our sites in Northern Ireland (Omagh, Dungannon, Campsie and Ballymoney) from Monday, 18th May 2020 safely, in compliance with local mandates and in response to customer demand and need. This decision follows the Department for the Economy’s recent publication of a list of priority business sectors that need to continue to operate during the COVID-19 in the UK.

Our primary focus during the COVID-19 pandemic is to ensure that we look after the health, safety and well-being of our workforce, and to do all that we reasonably can to protect our team members while at work. Our employees’ health and well-being is at the centre of our operations, and in order to keep our returning employees and workplace safe from the virus we have implemented comprehensive safety measures in line with Government guidance and Terex best practice.

Going forward, in addition to our other COVID-19 safety and preventive measures, we are introducing three compulsory enhanced measures to help protect the health and safety of team members and others who may need to come to our sites:

  1. Health Checks Upon Entrance: COVID-19 health check self-assessment utilising the Health and Social Care Application and no-touch temperature screening/checks to screen for high temperatures and avoid having sick persons on our site
  2. Face coverings will be mandatory for close working and/or face to face conversations
  3. Social distancing measures across the sites

These measures also extend to visitors to sites, and visitors will be on an essential basis only.

By taking a series of actions we can reduce risk and improve our confidence that we can operate in a safe work environment. We anticipate that these measures will be in place for the foreseeable future.

Our Leadership Team will continue to monitor the situation daily. The operation status of other Terex factories around the world is available here: www.terex.com/en/covid-19/manufacturing